Semaglutide, initially created to treat diabetes type 2, has recently made waves in the weight-loss industry. Results of clinical studies suggest it could provide substantial help with weight reduction.
As with all medications, semaglutide has both its positives and its drawbacks that must be evaluated carefully. Here we explore those aspects which make semaglutide an excellent treatment option for obesity as well as any possible drawbacks associated with its use.
Semaglutide is a GLP-1 receptor agonist designed to mimic its natural equivalent; GLP-1 hormone released upon food consumption plays a significant role in controlling blood sugar levels, increasing insulin production, slowing digestion and, crucially for weight loss, decreasing appetite.
Semaglutide (marketed under the label Ozempic and also available as Rybelsus ) was approved by the Food and Drug Administration to treat type 2 diabetes in 2017. Semaglutide must be administered via weekly injections; its primary goal being the management of condition; however weight loss has also been noted as an additional side benefit of taking Semaglutide.
Semaglutide Alleviates Heart Failure Symptoms
A recent research paper published in the New England Journal of Medicine demonstrated how semaglutide significantly alleviated heart failure symptoms among obese individuals suffering with this medical condition, including fatigue and breathlessness, while leading to significant improvements in physical ability and performance during exercise sessions.
Semaglutide May Lower Risk of Heart Attack and Stroke
Novo Nordisk-funded research discovered semaglutide can decrease heart attack and stroke risks by 20% among obese individuals with preexisting heart diseases; more study needs to be completed, however these initial results point toward this medication possibly helping decrease cardiovascular events for specific populations.
Potential as Preventive Medicine
Studies have proven the potential efficacy of semaglutide as a preventive drug against cardiovascular health risks for specific patients suffering from overweight, diabetes or cardiovascular risk factors; its use as preventive therapy will depend on availability and cost-efficiency considerations.
Semaglutide may provide that extra boost that’s needed in overcoming it all on its own. Semaglutide may help people lose weight through lean mass reduction. This involves water weight and muscle tissue. A decrease in lean mass can decrease your base metabolic rate (BMR), the rate at which energy is utilized when not working – leading to slower weight loss in the long term and making maintenance of weight loss harder to accomplish. Therefore, it’s crucial that they carefully weigh both advantages of weight loss as compared to potential risks from muscle attrition.
Semaglutide can also reduce appetite, which may aid weight loss; however, improper management could result in nutritional deficits; to make sure your body receives all of its necessary vitamins and minerals during your use of Semaglutide it’s vital that a balance be kept between diet and exercise while using this drug.